Cargando…

Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis

BACKGROUND: This study aims to evaluate specific risk factors influencing prognosis of HIV-infected patients with toxoplasma encephalitis (TE) in order to develop a prognostic risk scoring system for them. METHODS: This is a six-center retrospective study of hospitalized HIV/TE patients. Data includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yao, Zeng, Yan-Ming, Liu, Min, Lu, Yan-Qiu, Liu, Xue-Yan, Zhang, Yu-Lin, Jiang, Zhong-Sheng, Yang, Tong-Tong, Sun, Yan, Lan, Ke, Chen, Yao-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716502/
https://www.ncbi.nlm.nih.gov/pubmed/33276733
http://dx.doi.org/10.1186/s12879-020-05651-x
Descripción
Sumario:BACKGROUND: This study aims to evaluate specific risk factors influencing prognosis of HIV-infected patients with toxoplasma encephalitis (TE) in order to develop a prognostic risk scoring system for them. METHODS: This is a six-center retrospective study of hospitalized HIV/TE patients. Data including six-week mortality after diagnosis, baseline characteristics, clinical features, laboratory tests and radiological characteristics of eligible patients were assimilated for risk model establishing. RESULTS: In this study, the six-week mortality among 94 retrospective cases was 11.7% (11/94). Seven specific risk factors, viz. time from symptom onset to presentation, fever, dizziness, CD4+ T-cell counts, memory deficits, patchy brain lesions, and disorders of consciousness were calculated to be statistically associated with mortality. A criterion value of ‘9’ was selected as the optimal cut-off value of the established model. The AUC of the ROC curve of this scoring model was 0.976 (p < 0.001). The sensitivity and specificity of the risk scoring model was 100.0 and 86.9%, respectively, which were 81.8 and 94.1% of this scoring model in the verification cohort, respectively. CONCLUSIONS: The developed scoring system was established with simple risk factors, which also allows expeditious implementation of accurate prognostication, and appropriate therapeutic interventions in HIV-infected patients with TE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05651-x.